Primary pancreatic organoid tumor models for high-throughput phenotypic drug screening

(SLAS (Society for Laboratory Automation and Screening)) A multidisciplinary team of scientists share recent advancements in innovative in-vitro cancer biology methods for screening drug-like molecules in cancer tissue relevant models in a new report published online ahead-of-print at SLAS Discovery. Entitled Advanced Development of Primary Pancreatic Organoid Tumor Models for High-Throughput Phenotypic Drug Screening, the report can be accessed for free.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news